Barchart on MSN

What are Wall Street analysts' target price for Pfizer stock?

New York-based Pfizer Inc. (PFE) is a leading global biopharmaceutical company. With a market cap of $139.3 billion, it is ...

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Analysts expect the New York-based company to report quarterly earnings at 57 cents per share, down from 63 cents per share ...

Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure

Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its ...

Cantor Fitzgerald raises Pfizer (PFE) PT to $27 amid shifting obesity data focus

Pfizer Inc. (NYSE:PFE) is one of the most undervalued large cap stocks to invest in now. On January 27, Cantor Fitzgerald raised the firm’s price target on Pfizer to $27 from $24 and maintained a ...

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)

According to TipRanks.com, Schott is a 4-star analyst with an average return of 5.5% and a 58.1% success rate. Schott covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, ...